Atrial ablation catheter adapted for treatment of septal wall arrhythmogenic foci and method of use

An atrial ablation catheter with an electrode array particularly adapted to locate and ablate foci of arrhythmia which are required for sustained atrial fibrillation is provided. The array is easily deployed and retracted from the catheter, and presents a proximally oriented electrode array that can be pulled against the septal wall of the left atrium to engage the septal wall.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 10/997,713, filed Nov. 24, 2004, and entitled “Atrial Ablation Catheter Adapted for Treatment of Septal Wall Arrhythmogenic Foci and Method of Use”, now U.S. Pat. No. 7,468,062, issued Dec. 23, 2008.

INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

FIELD OF THE INVENTION

The inventions described below relate the field of atrial ablation.

BACKGROUND OF THE INVENTION

Atrial fibrillation is a form of arrhythmia, or irregular heartbeat, in which the atria (the two small upper chambers of the heart) quiver instead of beating effectively. While there are a number of variations of atrial fibrillation with different causes, they all involve irregularities in the transmission of electrical impulses through the heart. As a result of abnormalities in the heart's electrical impulses, the heart is not able to pump the blood out properly, and it may pool and clot. If a blood clot moves to an artery in the brain, AF can lead to stroke. AF is also associated with increased risks of congestive heart failure and cardiomyopathy. These risks warrant medical attention for patients with AF even if the symptoms are mild. Atrial fibrillation is the most common sustained heart rhythm disorder and increases the risk for heart disease and stroke, both leading causes of death in the United States. Over 2 million adults in the United States have been diagnosed with atrial fibrillation.

Various ablation techniques have been proposed to treat atrial fibrillation, including the Cox-Maze procedure, linear ablation of various regions of the atrium, and circumferential pulmonary vein ablation. Each of these techniques has its various drawbacks. The Cox-Maze procedure and linear ablation procedures are tedious and time-consuming, taking up to several hours to accomplish endocardially. Circumferential ablation is proving to lead to rapid stenosis and occlusion of the pulmonary veins, and of course is not applicable to treatment of the septal wall of the left atrium. The catheter mounted electrode arrays described in our co-pending patent application Kunis, et al., Atrial Ablation Catheter and Method of Use, U.S. application Ser. No. 10/997,172 filed Nov. 22, 2004 provide for more efficient and effective treatment of atrial fibrillation. The treatment of the septal wall is facilitated with the devices and methods described below, which permit septal wall treatment from a percutaneous venous access route without the need to maneuver a distally facing electrode array in apposition to the septal wall.

SUMMARY OF THE INVENTION

The devices and methods described below provide for a simplified approach to the treatment of atrial fibrillation with substantially improved efficacy and outcomes in patients with paroxysmal or persistent atrial fibrillation, especially for those arrhythmia originating from, or sustained by, arrhythmogenic foci located on the septal wall of the left atrium. An endocardial catheter with an electrode array particularly adapted to locate and ablate foci of arrhythmia which are required for sustained atrial fibrillation is provided. The array is easily deployed and retracted from the catheter, and presents a proximally oriented electrode array that can be pulled against the septal wall of the left atrium to engage the septal wall. A control system comprising an ECG analyzer and a RF power supply operates to analyze electrical signals obtained from the electrode array, determine if an arrhythmogenic focus is present in the area covered by the array, and supply RF power to appropriate electrodes to ablate the focus.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates the treatment to be accomplished with the devices and methods described below.

FIG. 2 illustrates an atrial sensing and ablation catheter with an expandable electrode array constrained within an outer catheter tube.

FIG. 3 is an enlarged view of the distal portion of the catheter of FIG. 2.

FIG. 4 is a cross-section of the distal portion of the catheter of FIG. 2.

FIG. 5 illustrates the atrial sensing and ablation catheter of FIG. 2 with the electrode array in its expanded configuration.

FIGS. 6 and 6a is an enlarged view of the electrode array in its expanded configuration.

FIG. 6b illustrates the meaning of the terminology which precisely defines the electrode array of FIGS. 5 and 6

FIG. 7 is an end view of the electrode array in its expanded configuration.

FIG. 7a is an end view of the electrode array, with an asymmetric arrangement of electrodes, in its expanded configuration.

FIGS. 8 and 9 illustrate the mechanism of recapture of the electrode array of the atrial ablation catheter.

FIGS. 10 and 10a illustrates an alternate geometry of the septal wall array.

FIG. 10b illustrates the meaning of the terminology which precisely defines the electrode array of FIGS. 10 and 10a.

FIGS. 11, 12 and 13 illustrate additional alternative geometries of the array.

FIGS. 14 and 15 illustrate the method of using the device of to treat the septal wall of the left atrium.

 DETAILED DESCRIPTION OF THE INVENTION

FIG. 1 illustrates the treatment to be accomplished with the devices and methods described below. FIG. 1 shows a cutaway view of the human heart 1, showing the major structures of the heart including the right atrium 2, the left atrium 3, the right ventricle 4, and the left ventricle 5. The atrial septum 6 separates the left and right atria. The fossa ovalis 7 is a small depression in the atrial septum which is easily punctured and easily heals. The percutaneous venous approach through the right atrium and the fossa ovalis is the preferred access pathway to the left atrium. In a patient suffering from atrial fibrillation, aberrant electrically conductive tissue may be found in the atrial walls 8 and 9, including the septal wall surrounding the fossa ovalis, as well as in the pulmonary veins 10 and pulmonary arteries 11. These areas of aberrant electrically conductive tissue, referred to as arrhythmogenic foci, drivers or rotors, cause or sustain atrial fibrillation. Ablation of these areas is an effective treatment for atrial fibrillation. Though circumferential ablation of the pulmonary veins cures the arrhythmia which originates in the pulmonary veins, it often results in rapid stenosis of the pulmonary veins. Ablation of foci, rotors or drivers on atrial walls, however, may prevent the propagation of any aberrant electrical activity that originates in the pulmonary veins, originates in other regions of the atrial wall, or originates on the septal wall itself.

To accomplish ablation of the septal wall of the left atrium, a catheter is inserted into the atrium, preferably through the inferior vena cava 20, as shown in the illustration, or through the superior vena cava 21, into the right atrium and then into left atrium. When passing into the left atrium, as illustrated, the catheter penetrates the fossa ovalis (a trans-septal puncture will facilitate the crossing). The catheter 22 carries a distal electrode array 23 into the atrium, and this electrode array is adapted to be pulled into contact with the section of the atrial wall surrounding the fossa ovalis. The electrode array is electrically connected to circuitry in a control system 24 which is operable to analyze electrical signals detected by the electrodes and pass RF current through the electrodes and heart tissue to ablate the tissue. A surface electrode 25 is mounted on the patient's body (typically on the back) to permit use of the electrodes in monopolar modes. A return electrode 26 may also be provided on the catheter 22, proximal to the electrode array. Using the catheter, an electrophysiologist will map regions of the septal wall of the left atrium and apply energy through the catheter to ablate any arrhythmogenic foci which are identified in the mapping procedure. The procedure may be repeated as necessary on the septal wall, rotating the array if necessary, to ablate all detected foci.

FIG. 2 illustrates an atrial sensing and ablation catheter 22 with an expandable electrode array. The catheter comprises a handle 30 with a steering control knob 31, electrical connector 32 and side-arm connector 33. The electrical connector is used to connect the catheter to the control box. An outer catheter tube 34 is slidably mounted on the inner catheter tube 35, and they may be releasably secured to each other by sliding the proximal portion of the outer catheter sheath strain relief 36 over the cylindrical detent 37 which is fixed to the handle. The side arm connector is used as a flushing port, to allow the flushing of debris and blood from the space between the inner and outer catheter tubes. The electrode array 23 is fixed to the inner catheter tube 35, and is restrained within the distal portion of the outer catheter tube 34.

FIG. 3 is an enlarged view of the distal portion of the catheter of FIG. 2. The electrode array 23 comprises a number of resiliently biased arms 39 which each carry a number of electrodes 40. An array of three arms, each of which carry four electrodes, is suitable for use in the atria. The arms each comprise a wire (preferably a flat wire) with a distal section 41, a proximal section 42 and an intervening bend section 43. The electrodes are placed on the proximal sections. The proximal end of each arm is fixed to the inner catheter tube 35. The distal end of each arm is fixed to the floating tube (or pin) 44. This floating tube is retained within the inner catheter tube, but is free to slide longitudinally within the inner catheter tube. The necessary electrical wires 45 and 46 which connect the electrodes to the control system run from each electrode proximally along the arm (and through any intervening electrodes), and enter the lumen of the floating tube 44 and then run proximally through the inner catheter tube and into the catheter handle. (Additional wires for temperature sensing thermistor or thermocouples may be included.) The wires are looped within the handle to provide the distension necessary for the resilient deployment of the electrode array as illustrated in FIG. 5. A steering pull wire 47 is secured to the distal end of the inner catheter tube. The pull wire runs proximally to the steering control knob in the proximal handle, and is operably connected to the control knob so that rotation of the control knob pulls the pull wire to effectuate steering of the distal end of the device. The outer catheter tube is sufficiently flexible so that it is steered by deflection of the inner catheter tube. The materials used for each component are selected to provide the suitable flexibility, column strength and steerability. The outer catheter tube 34 may comprises nylon, polyester or other suitable polymer, and the inner catheter tube 35 comprises a stainless steel coil covered in shrink tubing to provide tensile strength. The electrode arms 39 comprise flat nitinol wires. The floating tube 44 comprises a stainless steel coil. The floating tube may be disposed over the inner catheter if accommodations are made for proximal fixation of the proximal arm segments to the inner catheter, such as placing the fixation points proximally on the inner catheter or providing slots on the proximal portion of the floating tube. The electrode wires may be disposed on or in the wall of the inner catheter, rather than passing through the lumen of the inner catheter as shown in the Figures.

FIG. 4 is a cross-section of the proximal portion of the catheter of FIG. 2. At this cross section, an electrode 40 is mounted on each arm 39. These electrodes will be located on the proximally facing portion of the deployed array as shown in FIGS. 5 and 6. The electrodes are tubes of triangular cross section, with tissue contacting faces directed radially outwardly from the catheter. The electrode wires 45, which are connected to the inside electrodes, run through the outer electrodes on their route to the floating tube. The electrode wires 46 are fixed to the inner wall of the outer electrode. As shown in this view, the electrodes are collapsed upon the floating tube 44, and due to the triangular shape they are securely packed within the outer catheter tube 34. The floating tube 44 also houses the various electrode wires 45 and 46.

FIGS. 5 and 6 illustrate the atrial sensing and ablation catheter of FIG. 2 with the electrode array in its expanded configuration. The outer catheter tube 34 has been withdrawn proximally over the catheter inner tube, allowing the array arms 39 to expand to create array elements defining a substantially cordate or hastate proximal outline. The term cordate is used as it is in botany to describe a leaf with a base (where the leaf attaches to the stem) which is heart-shaped, having rounded lobes at the base which arch proximally away from the tip and then curve distally toward the tip of the leaf, as shown in FIG. 6b. The term hastate is also adopted from botany, and refers to proximally tending lobes with slightly curved proximal outlines and sharply bending tips, also as shown in FIG. 6b. In the array shown in FIGS. 5 and 6, the base of the array (the proximal portion analogous to the base of a leaf) is heart-shaped, having rounded lobes at the base which arch proximally away from the base and then curve outward and distally toward the tip of the array. Each proximal arm segment resiliently bends radially outwardly from the proximal connection with the inner catheter tube, bending sharply in the proximal direction before arching outwardly and distally, while each distal arm segment bends radially inwardly from the bend portion toward the longitudinally axis of the catheter.

The electrode array includes a number electrodes 40 mounted on the proximal section 42 of each array arm, and the distal section 41 need not have any electrodes disposed on it, as is shown. The overall shape of each arm is elongate on an axis perpendicular to the long axis of the catheter, having a radial length R which is several times the axial length A.

The resilient expansion of the electrode array pushes the floating tube 44 proximally into the inner catheter tube. When the outer catheter tube is pushed distally over the electrode array, the distal electrode arms will be forced distally, as the proximal segments are compressed inwardly starting from the proximal end, to first splay the distal segments toward and through a perpendicular relationship with the floating tube such that the joint between the arms and the floating tube is distal to the bend point, while drawing the floating tube distally within the inner catheter tube.

FIG. 7 is a proximal end view of the electrode array in its expanded configuration. In this view, the three-arm array is fully expanded resiliently. The array provides four electrodes on each of three arms evenly distributed about the floating tube 44. The electrode wires 45 and 46 (shown in FIG. 3) extend inwardly from the electrodes and run proximally down the floating tube. The arms are each separated from the adjacent arms by about 120°. The array, when deployed and flattened as shown, is preferably about 15 to 30 mm in diameter (to the outer extent of the arm), with each distal arm segment 41 being about 7.5 to 15 mm long. The diameter of the electrode group (from the center to the outer extent of the electrodes) is preferably about 2 to 30 mm. The wire width is preferable about 0.26 mm, and the distal face of the electrodes is preferably about 1 to 2 mm wide and 2 to 3 mm long (the illustrated electrodes are 2 mm wide and 1.6 mm wide). The electrode array can comprise any number of arms, and each arm can carry any number of electrodes, though the three arm array, with dimensions described above, is well suited for the septal wall ablation therapy. FIG. 7a is an end view of the electrode array, with an asymmetric arrangement of electrodes, in its expanded configuration. In this embodiment, each electrode is 2 mm long, and is fixed to the array arm with a 2 mm gap between adjacent electrodes. The inner electrode of the first set of electrodes 40a is placed at a distance of 2 mm (indicated by item d1) from the inner catheter tube 35 and each of the additional electrodes are placed with 2 mm gaps between each electrode, while the inner electrode of the second set of electrodes 40b is placed at a distance of 4 mm (indicated by item d2) from the inner catheter tube 35 and each of the additional electrodes are placed with 2 mm gaps between each electrode, and the inner electrode of the third set of electrodes 40c is placed at a distance of 6 mm (indicated by item d3) from the inner catheter tube 35 and each of the additional electrodes are placed with 2 mm gaps between each electrode. With the electrodes arranged in this asymmetric pattern on each of the otherwise symmetrical array arms, rotation of the array after ablation in one position will be less likely to result in seating the electrodes directly on a previously ablated section of the septal wall.

FIGS. 8 and 9 illustrate the mechanism of recapture of the electrode array. When the outer catheter tube 34 is pushed distally over the inner catheter tube 35 and the electrode array, the distal electrode arms 41 will be forced distally, as the proximal segments 42 are compressed inwardly starting from the proximal end, as shown in FIG. 8. This initially splays the distal segments toward a perpendicular relationship with the floating tube as shown in FIG. 8. As the outer catheter tube is translated further distally, such that the joint between the arms and the floating tube is distal to the bend point, the distal arm segments become further splayed, such that they are distal to the proximal arms segments. Because the distal arm segments are fixed to the floating tube, their movement distally draws the floating tube distally within the inner catheter tube. The array is completely captured when the outer catheter tube is translated fully forward to resume the position shown in FIGS. 2 and 3. As can be seen from the illustration, the bend sections provide a means for rotatably joining the distal arm segment to the proximal arm segment, and other suitable mechanisms, such as hinges, may be used instead.

FIGS. 10 and 10a illustrate an alternate geometry of the septal wall array. The outer catheter tube 34 has been withdrawn proximally over the catheter inner tube, allowing the array arms 39 to expand to create array elements defining a substantially sagittate proximal outline. We use the term sagittate as that term is used in botany, where it describes a leaf with a base (where the leaf attaches to the stem) which is arrow-shaped (the back end of the arrow), having sharply triangular lobes with generally straight sides at the base which bend proximally away from the tip and then sharply turn distally toward the tip of the leaf, as shown in FIG. 10b. Here, the array arms have sharply triangular lobes at the base which bend proximally away from the catheter and then sharply turn distally toward the tip of the array. Each proximal arm segment resiliently bends radially outwardly from the proximal connection with the inner catheter tube, bending sharply in the proximal direction, while each distal arm segment bends radially inwardly from the bend portion toward the longitudinally axis of the catheter. The floating tube 44 of FIG. 6 need not be used, as in this example the array distal arm segments are joined at their extreme distal ends to floating pins 51 which comprise proximally running segments that enter the inner catheter tube to provide the floating attachment of the distal arm segments to the catheter body. (Thus both floating pin or arm extensions, or the floating tube, and other suitable means, may be used to fix the distal end of the electrode arms in a radially central area while leaving the distal ends of the electrode arms freely translatable along the catheter longitudinal axis.) The electrode array can be restrained within the outer catheter tube, released and recaptured by sliding the outer catheter proximally or distally.

FIGS. 11, 12 and 13 illustrate additional alternative geometries of the array. In each device, the overall shape of the array arms may be as shown in any of the previous figures, but the array is asymmetrical or oblique. In FIG. 11, the array consists of a single arm 39, while in FIG. 12 the array comprises two arms disposed at a slight angle to each other, so that the array is radially asymmetrical. In FIG. 13, the array comprises an array arms 39 and 39a which are of substantial different sized, resulting in an oblique arrangement. Again, the term oblique is borrowed from botany, where it refers to leaves with lopsided proximal lobes, very similar to the lopsided proximal outlines of the array arms in FIG. 13. These arrays may be used where the anatomy of a particular patient's atrium demands, as where the fossa ovalis is positioned very near an upper or lower wall which would prevent full deployment of a symmetrical array.

FIGS. 14 and 15 illustrate the method of using the device of FIG. 6 or 10. FIG. 14 shows the heart 1 from the left side, showing the left atrium 3, the left ventricle 5, pulmonary veins 10, pulmonary artery 11. The left atrium is shown in a cutaway view, in which the atrial septum 6 and its left atrial surface 53 and the fossa ovalis 7 are shown. To treat arrhythmogenic foci, drivers or rotors on the septal wall near the fossa ovalis, the distal end of the catheter of FIG. 6 or 10 is inserted through the fossa ovalis (via the transeptal approach from the right atrium). Thereafter, the outer catheter is withdrawn, so that the electrode array arms 39 resiliently expand to the configuration in which the proximal arm segments are substantially parallel or slightly reflexed relative to the long axis of the catheter. As shown in FIG. 15, to engage the septal wall, the electrode array is pulled proximally into contact with the septal wall, by pulling proximally on the catheter inner tube 35. As shown, the array will deform, forcing the distal arm segments 41 to splay distally, drawing the floating posts or pins 51 distally in response to the deformation of the array, while at the same time resiliently biasing the proximal arm segments 42 and the electrodes 40 against the septal wall 53 of the left atrium.

After contact has been established between the atrium wall and the electrode array, the operator will analyze electrical signals detected by the electrodes to determine if the array has been placed over an arrhythmogenic focus. If it has, the operator may energize any of the electrodes, as appropriate, to ablate the focus. Bipolar RF energy may be applied between pairs of the electrodes, or monopolar energy may be applied to any of the electrodes (grounded to the surface electrode or a return electrode located proximally on the catheter body). The array may moved off the septal wall, rotated slightly, and reseated against the septal wall to test and treat the entire area surrounding the fossa ovalis with just a few array arms (alternatively, the array may be provided with many arms, such that the electrode density it sufficient to find an ablate all significant foci within its footprint). Linear lesions may be created using the electrodes along a single proximal arm, operating the electrodes in bipolar mode, and other therapeutic lesions may be created using electrodes pairs established between the electrodes of one arm and the electrodes of another arm, operating such pairs in bipolar mode, or operating electrodes in conjunction with return electrodes in a monopolar mode.

While the preferred embodiments of the devices and methods have been described in reference to the environment in which they were developed, they are merely illustrative of the principles of the inventions. Other embodiments and configurations may be devised without departing from the spirit of the inventions and the scope of the appended claims.

Claims

1. An ablation catheter configured to ablate septal wall tissue, comprising:

an elongate delivery tube defining a major axis and having a distal end adapted for insertion into the heart of a patient;
at least one resilient arm with a delivery configuration and an expanded configuration, wherein the at least one resilient arm comprises a distal arm section, a proximal arm section, and a bend section disposed between the distal arm section and the proximal arm section, the proximal arm section of the at least one resilient arm defining a shape selected from the group consisting of cordate, hastate, and sagittate when the at least one resilient arm is in the expanded configuration; and
a plurality of electrodes disposed on the proximal arm section of the at least one resilient arm, wherein the distal arm section defines a substantially linear configuration substantially orthogonal to the major axis when the at least one resilient arm is in the expanded configuration.

2. The ablation catheter of claim 1 wherein the at least one resilient arm is adapted to bend at the bend section when it is expanded from the delivery configuration to the expanded configuration.

3. The ablation catheter of claim 1 wherein the proximal arm section forms an acute angle with the distal arm section at the bend section when the at least one resilient arm is in the expanded configuration.

4. The ablation catheter of claim 1 further comprising a pin extending into the elongate delivery tube, the pin being longitudinally slidable relative to the elongate delivery tube.

5. The ablation catheter of claim 4 wherein the proximal arm section is attached to the elongate delivery tube and the distal arm section is attached to the pin.

6. The ablation catheter of claim 1 further adapted to map septal wall tissue.

7. The ablation catheter of claim 1 wherein the proximal arm section extends generally along a longitudinal axis of the elongate delivery tube when the at least one resilient arm is in the delivery configuration.

8. The ablation catheter of claim 1 wherein the distal arm section extends generally along a longitudinal axis of the elongate delivery tube when the at least one resilient arm is in the delivery configuration.

9. The ablation catheter of claim 1 wherein the proximal arm section is arcuate when the at least one resilient arm is in the expanded configuration.

10. An ablation catheter configured to ablate septal wall tissue, comprising:

an elongate delivery tube having a distal end adapted for insertion into the heart of a patient;
at least one resilient arm with a delivery configuration and an expanded configuration, wherein the at least one resilient arm comprises a distal arm section, a proximal arm section, and a bend section disposed between the distal arm section and the proximal arm section, the proximal arm section of the at least one resilient arm defining a shape selected from the group consisting of cordate, hastate, and sagittate when the at least one resilient arm is in the expanded configuration; and
a plurality of electrodes disposed on the proximal arm section of the at least one resilient arm, wherein the bend section is pre-formed in the at least one resilient arm and forms an acute angle with the distal arm section.

11. The ablation catheter of claim 10 wherein the at least one resilient arm is adapted to bend at the bend section when it is expanded from the delivery configuration to the expanded configuration.

12. The ablation catheter of claim 10 further comprising a pin extending into the elongate delivery tube, the pin being longitudinally slidable relative to the elongate delivery tube.

13. The ablation catheter of claim 12 wherein the proximal arm section is attached to the elongate delivery tube and the distal arm section is attached to the pin.

14. The ablation catheter of claim 10 further adapted to map septal wall tissue.

15. The ablation catheter of claim 10 wherein the proximal arm section extends generally along a lateral axis of the elongate delivery tube when the at least one resilient arm is in the expanded configuration.

16. The ablation catheter of claim 10 wherein the distal arm section extends generally along a lateral axis of the elongate delivery tube when the at least one resilient arm is in the expanded configuration.

17. The ablation catheter of claim 10 wherein the proximal arm section extends generally along a longitudinal axis of the elongate delivery tube when the at least one resilient arm is in the delivery configuration.

18. The ablation catheter of claim 10 wherein the distal arm section extends generally along a longitudinal axis of the elongate delivery tube when the at least one resilient arm is in the delivery configuration.

19. The ablation catheter of claim 10 wherein the proximal arm section is arcuate when the at least one resilient arm is in the expanded configuration.

20. An ablation catheter configured to ablate septal wall tissue, comprising:

an outer catheter tube defining a major axis and having a distal end adapted for insertion into the heart of a patient;
an inner catheter tube slidably disposed within the outer catheter tube;
a pin slidably disposed within the inner catheter tube;
at least one resilient arm with a delivery configuration and an expanded configuration, wherein the at least one resilient arm comprises a distal arm section attached to the pin, a proximal arm section attached to the inner catheter tube, and a bend section disposed between the distal arm section and the proximal arm section,
wherein the distal arm section defines a substantially linear configuration substantially orthogonal to the major axis when the at least one resilient arm is in the expanded configuration, and proximal arm section of the at least one resilient arm defines a shape selected from the group consisting of cordate, hastate, and sagittate when the at least one resilient arm is in the expanded configuration; and
a plurality of electrodes disposed on the proximal arm section of the at least one resilient arm.

21. The ablation catheter of claim 20 wherein the at least one resilient arm is adapted to bend at the bend section when it is expanded from the delivery configuration to the expanded configuration.

22. The ablation catheter of claim 20 further adapted to map the septal wall.

23. The ablation catheter of claim 20 wherein the proximal arm section is positioned outside of the outer catheter tube when the at least one resilient arm is in the expanded configuration.

24. The ablation catheter of claim 20 wherein the distal arm section is positioned outside of the outer catheter tube when the at least one resilient arm is in the expanded configuration.

25. The ablation catheter of claim 20 wherein the proximal arm section is positioned inside of the outer catheter tube when the at least one resilient arm is in the delivery configuration.

26. The ablation catheter of claim 20 wherein the distal arm section is positioned inside of the outer catheter tube when the at least one resilient arm is in the delivery configuration.

27. A method of treating atrial fibrillation comprising:

inserting an ablation catheter defining a major axis into the left atrium of the heart of a patient;
expanding a resilient arm of the ablation catheter by bending the resilient arm at a bend section in the resilient arm, wherein the resilient arm comprises proximal and distal arm sections extending from the bend section, the distal arm section defining a substantially linear configuration substantially orthogonal to the major axis when the resilient arm is substantially expanded, and the proximal arm section of the at least one resilient arm defining shape selected from the group consisting of cordate, hastate, and sagittate when the resilient arm is substantially expanded;
pulling the proximal arm section of the resilient arm into contact with septal wall tissue; and
passing energy through at least one electrode disposed on the proximal arm section to ablate the septal wall tissue.

28. The method of claim 27 further comprising sensing electrical signals of the septal wall tissue through the at least one electrode disposed on the proximal arm section.

29. The method of claim 28 further comprising repeating the passing energy and sensing steps on another area of septal wall tissue.

30. The method of claim 28 further comprising determining if the proximal arm section is disposed over an arrhythmogenic focus in the left atrium.

31. The method of claim 27 wherein the step of expanding the resilient arm further comprises bending the resilient arm until the proximal arm section extends generally along a lateral axis of the ablation catheter.

32. The method of claim 27 wherein the step of expanding the resilient arm further comprises bending the resilient arm until the distal arm section extends generally along a lateral axis of the ablation catheter.

33. The method of claim 27 further comprising removing an outer catheter tube from the resilient arm before expanding the resilient arm.

34. The method of claim 27 wherein the expanding step further comprises sliding a pin relative to a longitudinal axis of the ablation catheter.

Referenced Cited
U.S. Patent Documents
3516412 June 1970 Ackerman
3951136 April 20, 1976 Wall
4017903 April 12, 1977 Chu
4112952 September 12, 1978 Thomas et al.
4411266 October 25, 1983 Cosman
4432377 February 21, 1984 Dickhudt
4660571 April 28, 1987 Hess et al.
4699147 October 13, 1987 Chilson et al.
4785815 November 22, 1988 Cohen
4860769 August 29, 1989 Fogarty et al.
4869248 September 26, 1989 Narula
4882777 November 21, 1989 Narula
4896671 January 30, 1990 Cunningham et al.
4907589 March 13, 1990 Cosman
4920980 May 1, 1990 Jackowski
4940064 July 10, 1990 Desai
4966597 October 30, 1990 Cosman
5010894 April 30, 1991 Edhag
5016808 May 21, 1991 Heil, Jr. et al.
5083565 January 28, 1992 Parins
5100423 March 31, 1992 Fearnot
5156151 October 20, 1992 Imran
5184621 February 9, 1993 Vogel et al.
5215103 June 1, 1993 Desai
5228442 July 20, 1993 Imran
5230349 July 27, 1993 Langberg
5231987 August 3, 1993 Robson
5231995 August 3, 1993 Desai
5234004 August 10, 1993 Hascoet et al.
5239999 August 31, 1993 Imran
5255679 October 26, 1993 Imran
5279299 January 18, 1994 Imran
5281213 January 25, 1994 Milder et al.
5281218 January 25, 1994 Imran
5309910 May 10, 1994 Edwards et al.
5313943 May 24, 1994 Houser et al.
5318525 June 7, 1994 West et al.
5324284 June 28, 1994 Imran
5327889 July 12, 1994 Imran
5330466 July 19, 1994 Imran
5334193 August 2, 1994 Nardella
5342295 August 30, 1994 Imran
5342357 August 30, 1994 Nardella
5345936 September 13, 1994 Pomeranz et al.
5348554 September 20, 1994 Imran et al.
D351652 October 18, 1994 Thompson et al.
5364352 November 15, 1994 Cimino et al.
5365926 November 22, 1994 Desai
5370644 December 6, 1994 Langberg
5383917 January 24, 1995 Desai et al.
5391147 February 21, 1995 Imran et al.
5397304 March 14, 1995 Truckai
5397339 March 14, 1995 Desai
5400783 March 28, 1995 Pomeranz et al.
5404638 April 11, 1995 Imran
5406946 April 18, 1995 Imran
5411025 May 2, 1995 Webster, Jr.
5423808 June 13, 1995 Edwards et al.
5423811 June 13, 1995 Imran et al.
5433198 July 18, 1995 Desai
5433739 July 18, 1995 Sluijter et al.
5445148 August 29, 1995 Jaraczewski et al.
5462521 October 31, 1995 Brucker et al.
5462545 October 31, 1995 Wang et al.
5465717 November 14, 1995 Imran et al.
5471982 December 5, 1995 Edwards et al.
5487757 January 30, 1996 Truckai et al.
5492119 February 20, 1996 Abrams
5500011 March 19, 1996 Desai
5507802 April 16, 1996 Imran
5509411 April 23, 1996 Littmann et al.
5527279 June 18, 1996 Imran
5533967 July 9, 1996 Imran
5536267 July 16, 1996 Edwards et al.
5540681 July 30, 1996 Strul et al.
5545161 August 13, 1996 Imran
5545193 August 13, 1996 Fleischman et al.
5545200 August 13, 1996 West et al.
5558073 September 24, 1996 Pomeranz et al.
5573533 November 12, 1996 Strul
5575766 November 19, 1996 Swartz et al.
5575810 November 19, 1996 Swanson et al.
5578007 November 26, 1996 Imran
5582609 December 10, 1996 Swanson et al.
5584830 December 17, 1996 Ladd et al.
5588432 December 31, 1996 Crowley
5588964 December 31, 1996 Imran et al.
5595183 January 21, 1997 Swanson et al.
5596995 January 28, 1997 Sherman et al.
5598848 February 4, 1997 Swanson et al.
5601088 February 11, 1997 Swanson et al.
5606974 March 4, 1997 Castellano et al.
5607462 March 4, 1997 Imran
5620481 April 15, 1997 Desai et al.
5626136 May 6, 1997 Webster, Jr.
5630425 May 20, 1997 Panescu et al.
5630837 May 20, 1997 Crowley
5637090 June 10, 1997 McGee et al.
D381076 July 15, 1997 Thornton et al.
5645064 July 8, 1997 Littmann et al.
5645082 July 8, 1997 Sung et al.
5656029 August 12, 1997 Imran et al.
5657755 August 19, 1997 Desai
5658278 August 19, 1997 Imran et al.
5662606 September 2, 1997 Cimino et al.
5666970 September 16, 1997 Smith
5673695 October 7, 1997 McGee et al.
5680860 October 28, 1997 Imran
5681280 October 28, 1997 Rusk et al.
5682885 November 4, 1997 Littmann et al.
5685322 November 11, 1997 Sung et al.
5687723 November 18, 1997 Avitall
5693078 December 2, 1997 Desai et al.
5697927 December 16, 1997 Imran et al.
5697928 December 16, 1997 Walcott et al.
5699796 December 23, 1997 Littmann et al.
5702438 December 30, 1997 Avitall
5704791 January 6, 1998 Gillio
5706809 January 13, 1998 Littmann et al.
5711298 January 27, 1998 Littmann et al.
5716389 February 10, 1998 Walinsky et al.
5722401 March 3, 1998 Pietroski et al.
5722975 March 3, 1998 Edwards et al.
5724985 March 10, 1998 Snell et al.
5733323 March 31, 1998 Buck et al.
5735280 April 7, 1998 Sherman et al.
5741320 April 21, 1998 Thornton et al.
5766152 June 16, 1998 Morley et al.
5769791 June 23, 1998 Benaron et al.
5769847 June 23, 1998 Panescu et al.
5772590 June 30, 1998 Webster, Jr.
5775327 July 7, 1998 Randolph et al.
5782239 July 21, 1998 Webster, Jr.
5782760 July 21, 1998 Schaer
5782828 July 21, 1998 Chen et al.
5782899 July 21, 1998 Imran
5792140 August 11, 1998 Tu et al.
5800482 September 1, 1998 Pomeranz et al.
5810740 September 22, 1998 Paisner
5820568 October 13, 1998 Willis
5827272 October 27, 1998 Breining et al.
5837001 November 17, 1998 Mackey
5849028 December 15, 1998 Chen
5857464 January 12, 1999 Desai
5857997 January 12, 1999 Cimino et al.
5860920 January 19, 1999 McGee et al.
5863291 January 26, 1999 Schaer
5871523 February 16, 1999 Fleischman et al.
5873865 February 23, 1999 Horzewski et al.
5876399 March 2, 1999 Chia et al.
5881732 March 16, 1999 Sung et al.
5882333 March 16, 1999 Schaer et al.
5885278 March 23, 1999 Fleischman
5891027 April 6, 1999 Tu et al.
5891135 April 6, 1999 Jackson et al.
5891137 April 6, 1999 Chia et al.
5891138 April 6, 1999 Tu et al.
5893847 April 13, 1999 Kordis
5893884 April 13, 1999 Tu
5893885 April 13, 1999 Webster, Jr.
5895355 April 20, 1999 Schaer
5895417 April 20, 1999 Pomeranz et al.
5897554 April 27, 1999 Chia et al.
5904680 May 18, 1999 Kordis et al.
5906605 May 25, 1999 Coxum
5910129 June 8, 1999 Koblish et al.
5911720 June 15, 1999 Bourne et al.
5913854 June 22, 1999 Maguire et al.
5916214 June 29, 1999 Cosio et al.
5928191 July 27, 1999 Houser et al.
5931835 August 3, 1999 Mackey
5935063 August 10, 1999 Nguyen
5938694 August 17, 1999 Jaraczewski et al.
5941845 August 24, 1999 Tu et al.
5951471 September 14, 1999 de la Rama et al.
5954719 September 21, 1999 Chen et al.
5957842 September 28, 1999 Littmann et al.
5960796 October 5, 1999 Sung et al.
5967978 October 19, 1999 Littmann et al.
5968040 October 19, 1999 Swanson et al.
5971980 October 26, 1999 Sherman
5992418 November 30, 1999 de la Rama et al.
5997532 December 7, 1999 McLaughlin et al.
6001093 December 14, 1999 Swanson et al.
6001095 December 14, 1999 de la Rama et al.
6002956 December 14, 1999 Schaer
6004269 December 21, 1999 Crowley et al.
6014581 January 11, 2000 Whayne et al.
6021340 February 1, 2000 Randolph et al.
6023638 February 8, 2000 Swanson
6029091 February 22, 2000 de la Rama et al.
6032674 March 7, 2000 Eggers et al.
6033403 March 7, 2000 Tu et al.
6042580 March 28, 2000 Simpson
6045550 April 4, 2000 Simpson et al.
6048329 April 11, 2000 Thompson et al.
6049737 April 11, 2000 Simpson et al.
6050994 April 18, 2000 Sherman
6052612 April 18, 2000 Desai
6053937 April 25, 2000 Edwards et al.
6056744 May 2, 2000 Edwards
6059778 May 9, 2000 Sherman
6063077 May 16, 2000 Schaer
6063082 May 16, 2000 DeVore et al.
6064902 May 16, 2000 Haissaguerre et al.
6068629 May 30, 2000 Haissaguerre et al.
6070094 May 30, 2000 Swanson et al.
6071274 June 6, 2000 Thompson et al.
6071279 June 6, 2000 Whayne et al.
6071281 June 6, 2000 Burnside et al.
6071282 June 6, 2000 Fleischman
6074351 June 13, 2000 Houser
6086581 July 11, 2000 Reynolds et al.
6088610 July 11, 2000 Littmann et al.
6096036 August 1, 2000 Bowe et al.
6099524 August 8, 2000 Lipson et al.
6106522 August 22, 2000 Fleischman et al.
6107699 August 22, 2000 Swanson
6115626 September 5, 2000 Whayne et al.
6119041 September 12, 2000 Pomeranz et al.
6120476 September 19, 2000 Fung et al.
6129724 October 10, 2000 Fleischman et al.
6141576 October 31, 2000 Littmann et al.
6146379 November 14, 2000 Fleischman et al.
6146381 November 14, 2000 Bowe et al.
6165169 December 26, 2000 Panescu et al.
6167291 December 26, 2000 Barajas et al.
6171305 January 9, 2001 Sherman
6171306 January 9, 2001 Swanson et al.
6179833 January 30, 2001 Taylor
6200314 March 13, 2001 Sherman
6212426 April 3, 2001 Swanson
6214002 April 10, 2001 Fleischman et al.
6216043 April 10, 2001 Swanson et al.
6216044 April 10, 2001 Kordis
6217573 April 17, 2001 Webster
6217576 April 17, 2001 Tu et al.
6226542 May 1, 2001 Reisfeld
6231570 May 15, 2001 Tu et al.
6238390 May 29, 2001 Tu et al.
6241666 June 5, 2001 Pomeranz et al.
6241724 June 5, 2001 Fleischman et al.
6241725 June 5, 2001 Cosman
6241726 June 5, 2001 Raymond et al.
6241727 June 5, 2001 Tu et al.
6241728 June 5, 2001 Gaiser et al.
6241754 June 5, 2001 Swanson et al.
6245067 June 12, 2001 Tu et al.
6245089 June 12, 2001 Daniel et al.
6251107 June 26, 2001 Schaer
6256540 July 3, 2001 Panescu et al.
6264664 July 24, 2001 Avellanet
6267746 July 31, 2001 Bumbalough
6290697 September 18, 2001 Tu et al.
6293943 September 25, 2001 Panescu et al.
6302880 October 16, 2001 Schaer
6309385 October 30, 2001 Simpson
6312425 November 6, 2001 Simpson et al.
6319251 November 20, 2001 Tu et al.
6325797 December 4, 2001 Stewart et al.
6332880 December 25, 2001 Yang et al.
6332881 December 25, 2001 Carner et al.
6346104 February 12, 2002 Daly et al.
6353751 March 5, 2002 Swanson
6360128 March 19, 2002 Kordis et al.
6370435 April 9, 2002 Panescu et al.
6371955 April 16, 2002 Fuimaono et al.
6379352 April 30, 2002 Reynolds et al.
6389311 May 14, 2002 Whayne et al.
6391024 May 21, 2002 Sun et al.
6425894 July 30, 2002 Brucker et al.
6428536 August 6, 2002 Panescu et al.
6428537 August 6, 2002 Swanson et al.
6440129 August 27, 2002 Simpson
6447506 September 10, 2002 Swanson et al.
6451015 September 17, 2002 Rittman, III et al.
6454758 September 24, 2002 Thompson et al.
6456864 September 24, 2002 Swanson et al.
6460545 October 8, 2002 Kordis
6471693 October 29, 2002 Carroll et al.
6471699 October 29, 2002 Fleischman et al.
6475213 November 5, 2002 Whayne et al.
6475214 November 5, 2002 Moaddeb
6477396 November 5, 2002 Mest et al.
6478793 November 12, 2002 Cosman et al.
6485487 November 26, 2002 Sherman
6487441 November 26, 2002 Swanson et al.
6488678 December 3, 2002 Sherman
6490468 December 3, 2002 Panescu et al.
6493586 December 10, 2002 Stahmann et al.
6500167 December 31, 2002 Webster, Jr.
6500172 December 31, 2002 Panescu et al.
6514246 February 4, 2003 Swanson et al.
6517536 February 11, 2003 Hooven et al.
6522905 February 18, 2003 Desai
6529756 March 4, 2003 Phan et al.
6540744 April 1, 2003 Hassett et al.
6542773 April 1, 2003 Dupree et al.
6544262 April 8, 2003 Fleischman
6551271 April 22, 2003 Nguyen
6554794 April 29, 2003 Mueller et al.
6558378 May 6, 2003 Sherman et al.
6565511 May 20, 2003 Panescu et al.
6569114 May 27, 2003 Ponzi et al.
6569162 May 27, 2003 He
6569163 May 27, 2003 Hata et al.
6572612 June 3, 2003 Stewart et al.
6574492 June 3, 2003 Ben-Haim et al.
6575997 June 10, 2003 Palmer et al.
6583796 June 24, 2003 Jamar et al.
6597955 July 22, 2003 Panescu et al.
6602242 August 5, 2003 Fung et al.
6605087 August 12, 2003 Swartz et al.
6607505 August 19, 2003 Thompson et al.
6607520 August 19, 2003 Keane
6616657 September 9, 2003 Simpson et al.
6625482 September 23, 2003 Panescu et al.
6628976 September 30, 2003 Fuimaono et al.
6632223 October 14, 2003 Keane
6635056 October 21, 2003 Kadhiresan et al.
6638223 October 28, 2003 Lifshitz et al.
6638275 October 28, 2003 McGaffigan et al.
6640120 October 28, 2003 Swanson et al.
6652513 November 25, 2003 Panescu et al.
6652517 November 25, 2003 Hall et al.
6658279 December 2, 2003 Swanson et al.
6669692 December 30, 2003 Nelson et al.
6669693 December 30, 2003 Friedman
6671533 December 30, 2003 Chen et al.
6690972 February 10, 2004 Conley et al.
6701180 March 2, 2004 Desai
6702811 March 9, 2004 Stewart et al.
6711428 March 23, 2004 Fuimaono et al.
6730078 May 4, 2004 Simpson et al.
6738673 May 18, 2004 Desai
6740080 May 25, 2004 Jain et al.
6743225 June 1, 2004 Sanchez et al.
6746446 June 8, 2004 Hill, III et al.
6752804 June 22, 2004 Simpson et al.
6761716 July 13, 2004 Kadhiresan et al.
6805131 October 19, 2004 Kordis
6813520 November 2, 2004 Truckai et al.
6814732 November 9, 2004 Schaer
6830576 December 14, 2004 Fleischman et al.
6866662 March 15, 2005 Fuimaono et al.
6893438 May 17, 2005 Hall et al.
6893439 May 17, 2005 Fleischman
6893442 May 17, 2005 Whayne
6916306 July 12, 2005 Jenkins et al.
6936047 August 30, 2005 Nasab et al.
6939349 September 6, 2005 Fleischman et al.
6952615 October 4, 2005 Satake
6955173 October 18, 2005 Lesh
6960206 November 1, 2005 Keane
6961602 November 1, 2005 Fuimaono et al.
6964660 November 15, 2005 Maguire et al.
6966908 November 22, 2005 Maguire et al.
6972016 December 6, 2005 Hill, III et al.
6973339 December 6, 2005 Govari
6987995 January 17, 2006 Drysen
7001336 February 21, 2006 Mandrusov et al.
7025766 April 11, 2006 Whayne et al.
7029470 April 18, 2006 Francischelli et al.
7029471 April 18, 2006 Thompson et al.
7044135 May 16, 2006 Lesh
7047068 May 16, 2006 Haissaguerre
7048734 May 23, 2006 Fleischman et al.
7048756 May 23, 2006 Eggers et al.
7077823 July 18, 2006 McDaniel
7094235 August 22, 2006 Francischelli
7099711 August 29, 2006 Fuimaono et al.
7099712 August 29, 2006 Fuimaono et al.
7113831 September 26, 2006 Hooven
7115122 October 3, 2006 Swanson et al.
7118568 October 10, 2006 Hassett et al.
7122031 October 17, 2006 Edwards et al.
7151964 December 19, 2006 Desai et al.
7155270 December 26, 2006 Solis et al.
7156843 January 2, 2007 Skarda
7163537 January 16, 2007 Lee et al.
7429261 September 30, 2008 Kunis et al.
7857808 December 28, 2010 Oral et al.
20010029366 October 11, 2001 Swanson et al.
20010039415 November 8, 2001 Francischelli et al.
20010044625 November 22, 2001 Hata et al.
20010051803 December 13, 2001 Desai et al.
20020065465 May 30, 2002 Panescu et al.
20020120263 August 29, 2002 Brown et al.
20020126036 September 12, 2002 Flaherty et al.
20020161422 October 31, 2002 Swanson et al.
20030018330 January 23, 2003 Swanson et al.
20030093069 May 15, 2003 Panescu et al.
20030125730 July 3, 2003 Berube et al.
20030181819 September 25, 2003 Desai
20030195407 October 16, 2003 Fuimaono et al.
20030195501 October 16, 2003 Sherman et al.
20030199746 October 23, 2003 Fuimaono et al.
20030204185 October 30, 2003 Sherman et al.
20030204186 October 30, 2003 Geistert
20040015164 January 22, 2004 Fuimaono et al.
20040082947 April 29, 2004 Oral et al.
20040116921 June 17, 2004 Sherman et al.
20040133154 July 8, 2004 Flaherty et al.
20040138545 July 15, 2004 Chen et al.
20040143256 July 22, 2004 Bednarek
20040152980 August 5, 2004 Desai
20040158141 August 12, 2004 Scheib
20040181139 September 16, 2004 Falwell et al.
20040181249 September 16, 2004 Torrance et al.
20040182384 September 23, 2004 Alfery
20040236324 November 25, 2004 Muller et al.
20040247164 December 9, 2004 Furnish
20050010095 January 13, 2005 Stewart et al.
20050015084 January 20, 2005 Hill et al.
20050033137 February 10, 2005 Oral et al.
20050065512 March 24, 2005 Schaer
20050096644 May 5, 2005 Hall et al.
20050101946 May 12, 2005 Govari et al.
20050119651 June 2, 2005 Fuimaono et al.
20050148892 July 7, 2005 Desai
20050177146 August 11, 2005 Sherman
20050187545 August 25, 2005 Hooven et al.
20050234444 October 20, 2005 Hooven
20050240176 October 27, 2005 Oral et al.
20050251132 November 10, 2005 Oral et al.
20050256521 November 17, 2005 Kozel
20060030844 February 9, 2006 Knight et al.
20060084966 April 20, 2006 Maguire et al.
20060089637 April 27, 2006 Werneth et al.
20060095030 May 4, 2006 Avitall et al.
20060106375 May 18, 2006 Werneth et al.
20060111700 May 25, 2006 Kunis et al.
20060111701 May 25, 2006 Oral et al.
20060111702 May 25, 2006 Oral et al.
20060111703 May 25, 2006 Kunis et al.
20060111708 May 25, 2006 Vanney et al.
20060142753 June 29, 2006 Francischelli et al.
20060189975 August 24, 2006 Whayne et al.
20060195082 August 31, 2006 Francischelli
20060241366 October 26, 2006 Falwell et al.
20070083193 April 12, 2007 Werneth et al.
20070083194 April 12, 2007 Kunis et al.
20070083195 April 12, 2007 Werneth et al.
20070106293 May 10, 2007 Oral et al.
Foreign Patent Documents
5200671AA October 2005 AU
2327322AA November 1999 CA
2327518AA November 1999 CA
2328064AA November 1999 CA
2328070AA November 1999 CA
2371935AA December 2000 CA
2222617 July 2002 CA
2437140AA June 2004 CA
2492283AA July 2005 CA
2194061 April 2006 CA
2276755 May 2006 CA
2251041 June 2006 CA
428812 March 1995 EP
779059 June 1997 EP
598742 August 1999 EP
879016 October 2003 EP
1360938 November 2003 EP
1364677 November 2003 EP
1554986 July 2005 EP
823843 October 2005 EP
1384445 February 2006 EP
1169976 April 2006 EP
1415680 April 2006 EP
1011437 May 2006 EP
1210021 May 2006 EP
1658818 May 2006 EP
1125549 June 2006 EP
1182980 June 2006 EP
1207798 June 2006 EP
1321166 July 2006 EP
1343427 July 2006 EP
828451 September 2006 EP
1070480 September 2006 EP
1014874 December 2006 EP
1383437 December 2006 EP
1455667 January 2007 EP
957794 July 2007 EP
2004188179 July 2004 JP
1512622 October 1989 SU
1544396 February 1990 SU
1690786 November 1991 SU
WO90/06079 June 1990 WO
WO93/08756 May 1993 WO
WO93/25273 December 1993 WO
WO94/12098 June 1994 WO
WO96/10961 April 1996 WO
WO96/32885 October 1996 WO
WO96/32897 October 1996 WO
WO96/34558 November 1996 WO
WO96/34559 November 1996 WO
WO96/34560 November 1996 WO
WO96/34567 November 1996 WO
WO96/34569 November 1996 WO
WO96/34570 November 1996 WO
WO96/34650 November 1996 WO
WO96/34652 November 1996 WO
WO96/34653 November 1996 WO
WO96/36860 November 1996 WO
WO96/39967 December 1996 WO
WO97/15919 May 1997 WO
WO97/17893 May 1997 WO
WO97/17904 May 1997 WO
WO97/25917 July 1997 WO
WO97/25919 July 1997 WO
WO97/32525 September 1997 WO
WO97/36541 October 1997 WO
WO97/40760 November 1997 WO
WO97/42996 November 1997 WO
WO98/18520 May 1998 WO
WO98/19611 May 1998 WO
WO98/26724 June 1998 WO
WO98/28039 July 1998 WO
WO98/38913 September 1998 WO
WO99/02096 January 1999 WO
WO99/56644 November 1999 WO
WO99/56647 November 1999 WO
WO99/56648 November 1999 WO
WO99/56649 November 1999 WO
WO00/78239 December 2000 WO
WO02/060523 August 2002 WO
WO03/041602 May 2003 WO
WO03/089997 October 2003 WO
WO2005/027765 March 2005 WO
WO2005/027766 March 2005 WO
WO2005/065562 July 2005 WO
WO2005/065563 July 2005 WO
WO2005/104972 November 2005 WO
WO2006/017517 February 2006 WO
WO2006/044794 April 2006 WO
WO2006/049970 May 2006 WO
WO2006/052651 May 2006 WO
WO2006/052905 May 2006 WO
WO2006/055654 May 2006 WO
WO2006/055658 May 2006 WO
WO2006/055733 May 2006 WO
WO2006/055741 May 2006 WO
Other references
  • Oral et al.; U.S. Appl. No. 11/932,378 entitled “Ablation catheters and methods for their use,” filed Oct. 31, 2007.
  • “Werneth et al.; U.S. Appl. No. 12/116,753 entitled”“Ablation therapy system and method for treating continuous atrial fibrillation,”“filed May 7, 2008”.
  • Sherman et. al. ; U.S. Appl. No. 12/117,596 entitled “RF energy delivery system and method,”filed May 8, 2008.
  • Kunis et al.; U.S. Appl. No. 12/197,425 entitled “Atrial ablation catheter and method of use,” filed Aug. 25, 2008.
  • Werneth et al.; U.S. Appl. No. 12/245,625 entitled “Ablation catheter,” filed Oct. 3, 2008.
  • Nademanee et al., “A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate,” JACC, vol. 43, No. 11, pp. 2044-2053, 2004.
  • Wittkampf et al., “Radiofrequency ablation with a cooled porous electrode catheter,” (abstract) JACC, vol. 11, No. 2, pp. 17a, Feb. 1988.
Patent History
Patent number: 9005194
Type: Grant
Filed: Jul 18, 2008
Date of Patent: Apr 14, 2015
Patent Publication Number: 20080275443
Assignee: Medtronic Ablation Frontiers LLC (Minneapolis, MN)
Inventors: Hakan Oral (Ann Arbor, MI), Randell L. Werneth (San Diego, CA), Thomas M. Castellano (Temecula, CA), Christopher G. Kunis (San Diego, CA)
Primary Examiner: Michael Peffley
Application Number: 12/176,115
Classifications
Current U.S. Class: Applicators (606/41); Microwave Or Rf (high Frequency) (607/101); Catheter Or Endocardial (inside Heart) Type (607/122)
International Classification: A61B 18/14 (20060101); A61B 18/00 (20060101);